logo
logo
  • Products
    • Cell-Kro
    • VasaPlex
  • About
  • Publications
  • News
  • Contact Us

Publications

CTGF-D4 Amplifies LRP6 Signaling to Promote Grafts of Adult Epicardial-derived Cells That Improve Cardiac Function After Myocardial Infarction


by Samba BioLogics

Human Growth Factor/Immunoglobulin Complexes for Treatment of Myocardial Ischemia-Reperfusion Injury


by Samba BioLogics

Human Epicardial Cell-conditioned Medium Contains HGF/IgG Complexes that Phosphorylate RYK and Protect Against Vascular Injury


by Samba BioLogics

Priming with Ligands Secreted by Human Stromal Progenitor Cells Promotes Grafts of Cardiac Stem/Progenitor Cells After Myocardial Infarction


by Samba BioLogics

Recent Posts

  • Samba BioLogics Selected for MassBio’s Biotech Accelerator, MassBioDrive in Spring 2023 Cohort of Startups
  • CTGF-D4 Amplifies LRP6 Signaling to Promote Grafts of Adult Epicardial-derived Cells That Improve Cardiac Function After Myocardial Infarction
  • Samba BioLogics, Inc. Awarded NIH SBIR/STTR Program Grant
  • Human Growth Factor/Immunoglobulin Complexes for Treatment of Myocardial Ischemia-Reperfusion Injury
  • Samba BioLogics Selected for NIH-sponsored DRIVEN Program

Recent Comments

No comments to show.

Archives

  • April 2023
  • March 2022
  • February 2022
  • April 2020
  • August 2016
  • May 2015
  • March 2014
  • December 2013
  • December 2009

Categories

  • Articles
  • News
  • Publications

Developing breakthrough therapies for regenerative medicine to improve quality of life.

Contact

  • (802) 372-1199
  • info@sambabiologics.com

Explore

  • About Us
  • Publications
  • News
  • Contact

© 2025 Samba BioLogics, Inc. All rights reserved. Patents

— info@sambabiologics.com
Ask for Quote